According to a May 2024 analysis by the watchdog group Public Citizen, from 1991 to 2021, the government won payments of $62.3 billion in penalties from pharmaceutical companies. But the group observed, “This total amounts to a small percentage of the $1.9 trillion in net income made by the 35 largest drug companies during just 19 of those 31 years (2000–2018).”
